• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Discovery may bolster chemotherapy potency while protecting the heart from side-effects

Bioengineer by Bioengineer
February 6, 2019
in Cancer
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

University of Alberta medical researchers take significant step toward improving cancer care

IMAGE

Credit: Jordan Carson


Researchers from the University of Alberta may have found a way to make chemotherapy more effective at treating cancer while blocking its harmful side-effects on the heart.

While chemotherapy can be an effective treatment for cancer, the aggressive attack on cancer cells often cause damage to other cells throughout the body, including the heart, making patients more prone to develop heart problems years down the road.

“At the clinical level, we’ve known for some time that heart dysfunction from chemotherapy is a major issue, but at the scientific level, we’ve only recently begun to look at signalling pathways that may be implicated in this condition,” said Gopi Sutendra, Alberta Innovates Translational Health Chair in Cardio-Oncology at the U of A.

“This is the first targeted therapy at the preclinical level to actually prevent the side-effects of chemotherapy on the heart and simultaneously enhance tumour regression.”

The heart resides in an oxygen-rich environment, compared to a tumour which resides in an oxygen-poor environment.

The team found that the oxidation of proteins–a process that requires oxygen–was preferentially increased in the heart. By stabilizing a specific metabolic protein called pyruvate kinase M2 (PKM2)–also preferentially oxidized in the heart–with a drug compound, the researchers completely prevented heart damage from the chemotherapy, and enhanced the potency of the chemotherapy against lung tumours in preclinical mouse models.

According to Sutendra, chemotherapy affects all tissue, but the heart is especially susceptible. While most other cells will recover quickly, heart cells regenerate more slowly, making damage nearly irreversible. Because of that, protecting heart cells before the damage is done is vitally important.

The researchers hope the findings will soon be able to be tested in clinical trials with similar drugs that stabilize PKM2.

“The beauty of our work is that many of these drugs are already being tried in early-phase clinical trials for other diseases,” said Sutendra. “We’re really happy because we think that we can push it to the next phase where hopefully patients can start seeing some of these treatments in the near future.”

“We also believe the implications of our work may extend to other forms of heart failure as well,” added Bruno Saleme, first author on the study and a recent recipient of the Alberta Innovates Graduate Scholarship.

###

The research, published as a cover story in Science Translational Medicine, was supported by funding from the Canadian Institutes of Health Research, the Heart and Stroke Foundation and the Alberta Innovates Translational Health Chair in Cardio-Oncology.

Media Contact
Ross Neitz
rneitz@ualberta.ca
780-492-5986

Tags: Breast CancercancerCardiologyMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Oral Ceralasertib Combined with Durvalumab Shows Antitumor Activity in Phase I Trial

Oral Ceralasertib Combined with Durvalumab Shows Antitumor Activity in Phase I Trial

November 18, 2026
Cesium-131 Brachytherapy Tiles Achieve High Local Control in Recurrent Glioblastoma

Cesium-131 Brachytherapy Tiles Achieve High Local Control in Recurrent Glioblastoma

November 18, 2026

Vamotinib Resistance Profile Matches Second-Generation Tyrosine Kinase Inhibitors in Leukemia Study

November 18, 2026

Case Report Details Inherited ATM Gene Mutation in Aggressive Familial Prostate Cancer

November 18, 2026
Please login to join discussion

POPULAR NEWS

  • Over Forty Percent of Northeast Ethiopian Neonates Experience Early Cord Clamping

    Over Forty Percent of Northeast Ethiopian Neonates Experience Early Cord Clamping

    29 shares
    Share 12 Tweet 7
  • Biomimetic Hydroxyapatite Coating Restores Elastic Modulus in Recycled Aggregate Concrete

    29 shares
    Share 12 Tweet 7
  • Early Shoulder Mobilization Accelerates Initial Motion but Yields Equivalent Annual Outcomes

    29 shares
    Share 12 Tweet 7
  • SGLT2 Inhibitor Use Associated With Lower Proteinuria Rates During Bevacizumab Therapy

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Probiotic Strain Protects Mice Against Salmonella Infection by Preserving Gut Barrier Integrity

Optogenetic Slow-Wave Restoration Halts Alzheimer’s Pathology in Preclinical Brain Circuits

Defining Super-Enhancer Regulatory Landscapes in Health and Disease Progression

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.